# A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

> clinical trial · VERIFIED · 2026-08-19

Status: RECRUITING · Sponsor: ETOP IBCSG Partners Foundation · Condition: Extensive Stage Lung Small Cell Cancer

- Company: ETOP IBCSG Partners Foundation
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07203053

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.